Publications
228
Citations
42,792
Est. group size
~2
Recurring co-author estimate
Active years
28
Publishing since 1999
Colleen M. Cebulla's research centers on eye diseases, especially uveal (eye) melanoma, proliferative vitreoretinopathy (a scarring disease affecting retinal detachment repair), and retinal degeneration. Her work spans laboratory studies of disease mechanisms and genetic risk, as well as clinical and translational research on cancer therapies and outcomes for eye conditions such as age-related macular degeneration and BAP1 tumor predisposition syndrome. This work draws on genomics, cell biology, and clinical case studies to better understand and treat ocular cancers and retinal disorders.
Publication output was highest around 2018 and has generally declined since, with a notable dip between 2022 and 2024 followed by a modest uptick in 2025-2026.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- MIF inhibition attenuates proliferative vitreoretinopathy pathogenesis and protects the eye in preclinical model
Biomedicine & Pharmacotherapy · 2026
- “BAP1 Loss Induces Senescence and Enhances the Response to Radiation Therapy and Senolytics”
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- GWAS meta-analysis provides new insights into uveal melanoma risk
British Journal of Cancer · 2026
- Exceptional Response of Therapy-Resistant SF3B1 Mutant Conjunctival Melanoma to Nivolumab/LAG3 Inhibitor Relatlimab Combination Therapy: A Case Report
Case Reports in Oncology · 2025
- O-067 Importance of platelet function testing in predicting pipeline flow diverter asymptomatic DWI+ procedural thromboembolic events
2023
- Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
Frontiers in Oncology · 2022
- TMEM97 ablation aggravates oxidant-induced retinal degeneration
Cellular Signalling · 2021
- Is Uveal Melanoma a Hormonally Sensitive Cancer? A Review of the Impact of Sex Hormones and Pregnancy on Uveal Melanoma
Ocular Oncology and Pathology · 2021
- Estrogen Receptor Is Expressed in Uveal Melanoma: A Potential Target for Therapy
Ocular Oncology and Pathology · 2021
- Multimodal imaging and functional analysis of the chick NMDA retinal damage model
PLoS ONE · 2021
- Isolated Diffuse Choroidal Hemangioma: A Variant of Sturge-Weber Syndrome?
Journal of Pediatric Ophthalmology & Strabismus · 2020
- Table 5. [Recommended Surveillance for Individuals with BAP1 Tumor Predisposition Syndrome].
2020
- Effects of age on chick light adapted ERGs with and without inner retinal excitotoxic damage
Investigative Ophthalmology & Visual Science · 2020
- Differential effects of MIF inhibitors on an in vitro PVR model
Investigative Ophthalmology & Visual Science · 2020
- Cryopyrin-associated periodic syndrome presenting with posterior scleritis
Lara D. Veeken · 2019
- Investigative Ophthalmology & Visual Science×22
- Cell Reports×12
- Cell×9
- Cancer Cell×7
- Ocular Oncology and Pathology×4
- Mohamed H. Abdel‐Rahman
Medicine · The Ohio State University
- N. Horgan
Medicine · Purdue University West Lafayette
- Frederick H. Davidorf
Medicine · The Ohio State University
- H. Boutrid
Medicine · The Ohio State University
- Mark W. Reid
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile